NO931014L - Farmasoeytisk preparat - Google Patents

Farmasoeytisk preparat

Info

Publication number
NO931014L
NO931014L NO93931014A NO931014A NO931014L NO 931014 L NO931014 L NO 931014L NO 93931014 A NO93931014 A NO 93931014A NO 931014 A NO931014 A NO 931014A NO 931014 L NO931014 L NO 931014L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
angiotensin
pharmaceutical composition
composition containing
receptor antagonist
Prior art date
Application number
NO93931014A
Other languages
English (en)
Norwegian (no)
Other versions
NO931014D0 (no
Inventor
Werner Mederski
Dieter Dorsch
Rolf Gericke
Manfred Baumgarth
Pierre Schelling
Rolf Bergmann
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO931014D0 publication Critical patent/NO931014D0/no
Publication of NO931014L publication Critical patent/NO931014L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO93931014A 1992-03-20 1993-03-19 Farmasoeytisk preparat NO931014L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4209071A DE4209071A1 (de) 1992-03-20 1992-03-20 Pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
NO931014D0 NO931014D0 (no) 1993-03-19
NO931014L true NO931014L (no) 1993-09-21

Family

ID=6454609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931014A NO931014L (no) 1992-03-20 1993-03-19 Farmasoeytisk preparat

Country Status (13)

Country Link
EP (1) EP0561357A1 (es)
JP (1) JPH0648961A (es)
KR (1) KR930019215A (es)
CN (1) CN1076357A (es)
AU (1) AU3528593A (es)
CA (1) CA2091942A1 (es)
DE (1) DE4209071A1 (es)
HU (1) HUT63764A (es)
MX (1) MX9301546A (es)
NO (1) NO931014L (es)
PL (1) PL298159A1 (es)
TW (1) TW237384B (es)
ZA (1) ZA931984B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
DE4004268A1 (de) * 1990-02-13 1991-08-14 Merck Patent Gmbh Pharmazeutische zubereitung

Also Published As

Publication number Publication date
KR930019215A (ko) 1993-10-18
HUT63764A (en) 1993-10-28
CN1076357A (zh) 1993-09-22
ZA931984B (en) 1993-10-19
DE4209071A1 (de) 1993-09-23
PL298159A1 (en) 1993-10-18
HU9300796D0 (en) 1993-06-28
JPH0648961A (ja) 1994-02-22
AU3528593A (en) 1993-09-23
MX9301546A (es) 1993-09-01
EP0561357A1 (de) 1993-09-22
CA2091942A1 (en) 1993-09-21
NO931014D0 (no) 1993-03-19
TW237384B (es) 1995-01-01

Similar Documents

Publication Publication Date Title
PT873295E (pt) Moduladores de rxr selectivos para dimeros para a sua utilizacao
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
DK0720609T3 (da) 3-(5-Tetrazolylbenzyl)aminoperidinderivater og antagonister for tachykininer
NO20004743D0 (no) Farmasøytiske blandinger inneholdende irbesartan og et diuretium
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
NO941161D0 (no) Flyveaske-sementeringssammensetninger og metoder
NO933475D0 (no) Settingsretarderende tilsetningsstoffer, sammensetninger og fremgangsmaater for sement
NO981146D0 (no) Transcytotiske midler og forsterkere for medikamentleveranser
NO931496L (no) Kaks-sementsammensetninger og fremgangsmaater for anvendelse derav
DE69429861D1 (de) Endothelin-rezeptor-antagonisten
DE69331175D1 (de) Interleukin-2 Rezeptor Gamma-Kette
BR9200323A (pt) Formulacao de tiol-eno curavel,e sua composicao
ATA156496A (de) Pharmazeutische zusammensetzung
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
NO931014L (no) Farmasoeytisk preparat
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
NO20000107L (no) Ny blanding
NO990322D0 (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
DE69526738D1 (de) Endothelin-rezeptor-antagonisten
IT1263804B (it) Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
MXPA04001878A (es) Composiciones medicinales que comprenden antagonista del receptor de angiotensina ii.
FI941118A (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
NO960796L (no) Benzotiofenonforbindelser, mellomprodukter, sammensetninger og fremgangsmåter